BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Behrens F, Funk-Hilsdorf TC, Kuebler WM, Simmons S. Bacterial Membrane Vesicles in Pneumonia: From Mediators of Virulence to Innovative Vaccine Candidates. Int J Mol Sci 2021;22:3858. [PMID: 33917862 DOI: 10.3390/ijms22083858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kotlyarov S, Kotlyarova A. Molecular Mechanisms of Lipid Metabolism Disorders in Infectious Exacerbations of Chronic Obstructive Pulmonary Disease. Int J Mol Sci 2021;22:7634. [PMID: 34299266 DOI: 10.3390/ijms22147634] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Long Q, Zheng P, Zheng X, Li W, Hua L, Yang Z, Huang W, Ma Y. Engineered bacterial membrane vesicles are promising carriers for vaccine design and tumor immunotherapy. Adv Drug Deliv Rev 2022;186:114321. [PMID: 35533789 DOI: 10.1016/j.addr.2022.114321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gaurivaud P, Tardy F. The Mycoplasma spp. ‘Releasome’: A New Concept for a Long-Known Phenomenon. Front Microbiol 2022;13:853440. [DOI: 10.3389/fmicb.2022.853440] [Reference Citation Analysis]
4 Parveen S, Subramanian K. Emerging Roles of Extracellular Vesicles in Pneumococcal Infections: Immunomodulators to Potential Novel Vaccine Candidates. Front Cell Infect Microbiol 2022;12:836070. [DOI: 10.3389/fcimb.2022.836070] [Reference Citation Analysis]
5 Osterloh A. Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria. Vaccines 2022;10:751. [DOI: 10.3390/vaccines10050751] [Reference Citation Analysis]